Gene Symbol: RPL7A (Ribosomal Protein L7A)
Chromosomal Location: 9q34.3
NCBI Gene ID: 6132
UniProt ID: P62424
Path: /genes/rpl7a
RPL7A encodes Ribosomal Protein L7A, a fundamental component of the large (60S) ribosomal subunit. As one of approximately 47 ribosomal proteins in the eukaryotic ribosome, RPL7A plays essential roles in ribosome assembly, protein synthesis, and translational regulation. While traditionally viewed as a "housekeeping" protein, emerging research reveals important neuron-specific functions and dysregulation in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
The human RPL7A gene spans approximately 7.5 kb on chromosome 9q34.3 and consists of:
RPL7A is a 266-amino acid protein with a molecular weight of approximately 30 kDa. Key structural features include:
The protein contains:
Within the 60S subunit, RPL7A is located:
RPL7A is ubiquitously expressed across all tissues, with highest levels in:
| Region | Expression Level | Notes |
|---|---|---|
| Cerebral Cortex | High | Pyramidal neurons, interneurons |
| Hippocampus | High | CA1-CA3 regions, dentate gyrus |
| Cerebellum | High | Purkinje cells, granule cells |
| Basal Ganglia | Moderate | Striatal medium spiny neurons |
| Substantia Nigra | Moderate | Dopaminergic neurons |
| Spinal Cord | Moderate | Motor neurons |
Ribosomal dysfunction is a well-documented feature of AD:
Translational deficit: Reduced global translation in AD brains correlates with cognitive decline. RPL7A levels are altered in vulnerable regions.
Ribosome quality control: Impaired ribosome recycling leads to stalled translation complexes that accumulate as stress granules.
Synaptic translation: Specific deficits in synaptic translation machinery underlie memory impairment. RPL7A in synaptosomes shows decreased activity.
Tau pathology: Ribosomal dysfunction precedes tau aggregation in animal models.
Amyloid effects: Aβ oligomers directly impair ribosomal function through:
In PD, RPL7A dysregulation contributes to:
Dopaminergic neuron vulnerability: Reduced translation capacity makes neurons susceptible to stress.
α-Synuclein translation: Altered ribosomal function affects α-synuclein synthesis rates.
Mitochondrial stress response: Ribosomal proteins coordinate stress response translation.
Protein homeostasis: Impaired translation contributes to aggresome formation.
RPL7A in ALS:
Motor neuron-specific vulnerability: Motor neurons have high translational demands.
Stress granule formation: RPL7A is recruited to stress granules in ALS models.
C9orf72 translation: Dysregulated translation of expanded repeat transcripts.
Ribosomal RNA modification: Altered rRNA methylation in ALS.
RPL7A participates in several key processes:
mRNA → 43S pre-initiation complex → 48S initiation complex
↓
80S ribosome (RPL7A)
↓
Elongation (RPL7A)
↓
Termination → Protein
| Partner | Interaction | Functional Effect |
|---|---|---|
| rRNA 28S | Direct binding | Ribosome structural integrity |
| RPL5 | Protein interaction | 60S assembly |
| RPL11 | Complex formation | 60S subunit stability |
| eEF-1A | Factor binding | Translation elongation |
| eEF-2 | Coordination | Translocation |
| RACK1 | Scaffold protein | Signaling integration |
RPL7A integrates cellular stress responses:
Integrated stress response (ISR): Phosphorylation of eIF2α reduces global translation while selecting mRNAs for preferential translation.
Unfolded protein response (UPR): Ribosomal quality control initiates UPR signaling.
Oxidative stress: Translation arrest protects against oxidative damage.
Hypoxia: RPL7A modification adapts translation to oxygen availability.
Ribosomal dysfunction represents an emerging mechanism in neurodegeneration:
While RPL7A is not a primary causative gene, variants may influence:
RPL7A encodes a fundamental ribosomal protein essential for protein synthesis in all cells, including neurons. While traditionally considered a housekeeping gene, its dysregulation contributes to multiple neurodegenerative diseases through impaired translation, stress granule formation, and proteostasis failure. Understanding RPL7A's role in ribosomal function provides insight into neuronal vulnerability and may reveal therapeutic targets for AD, PD, ALS, and related disorders.
Neurons have particularly high translational requirements:
RPL7A participates in quality control mechanisms:
While RPL7A is not a mitoribosomal protein, mitochondrial translation intersects with:
| Model | Application | Key Findings |
|---|---|---|
| Primary neurons | Translation studies | RPL7A in synaptic translation |
| iPSC neurons | Disease modeling | Patient-specific ribosomal function |
| Astrocyte cultures | Glial contribution | Non-neuronal translation |
| Organotypic brain slices | Circuit analysis | Regional translation differences |
RPL7A assembly into the 60S subunit involves:
Ribosome biogenesis is tightly regulated by:
Ribosomal function declines with age:
Potential anti-aging strategies:
| Year | Milestone | Significance |
|---|---|---|
| 1970s | RPL7A identified | First characterization |
| 1990s | Ribosome structure | Atomic resolution |
| 2000s | Ribosomal dysfunction in AD | Disease connection |
| 2010s | RAQC mechanisms | Quality control |
| 2020s | Ribosome-quality control | Therapeutic targeting |
| Protein | Function | Expression | Disease Link |
|---|---|---|---|
| RPL7A | 60S component | Ubiquitous | AD, PD, ALS |
| RPL5 | 60S component | Ubiquitous | p53 regulation |
| RPL11 | 60S component | Ubiquitous | Ribosome assembly |
| RPS6 | 40S component | Ubiquitous | mTOR signaling |
| RPS3 | 40S component | Ubiquitous | DNA repair |